Research articles

Filter By:

Article Type
Year
  • Post-translational modifications (PTMs) of lysine side chains are important mediators of protein-protein interactions, particularly in chromatin. Photo-lysine, a diazirine analog of lysine, provides a tool to covalently capture proteins that bind lysine and its PTMs.

    • Tangpo Yang
    • Xiao-Meng Li
    • Xiang David Li
    Brief Communication
  • Cremeomycin is a diazo-containing natural product. Assignment of the functions of individual enzymes in the gene cluster for cremeomycin biosynthesis reveals a pathway by which Streptomyces cremeus converts L-aspartic acid into the nitrous acid needed for diazotization chemistry.

    • Yoshinori Sugai
    • Yohei Katsuyama
    • Yasuo Ohnishi
    Brief Communication
  • Applying an in vivo bacterial-based system for monitoring the influence of small molecules on the aggregation of model amyloid proteins expressed in the periplasm identified dopamine as a new inhibitor of hIAPP aggregation, a protein involved in type 2 diabetes mellitus.

    • Janet C Saunders
    • Lydia M Young
    • Sheena E Radford
    Article
  • Cyclophilin A binds a proline motif in human CrkII, preventing phosphorylation by Abl and EGFR. Decreased CrkII phosphorylation ensures interactions with the focal adhesion proteins paxillin and p130CAS to stimulate cellular migration.

    • Tamjeed Saleh
    • Wojciech Jankowski
    • Charalampos G Kalodimos
    Article
  • A new technology platform called μSCALE combines the use of a microcapillary array with laser-based extraction to enable high-throughput biochemical and biophysical analysis and isolation of protein variants for protein-engineering applications.

    • Bob Chen
    • Sungwon Lim
    • Jennifer R Cochran
    Article
  • The binding of small-molecule inhibitors of the RSV F glycoprotein in a central cavity in the prefusion conformation stabilizes this conformation and blocks the conformational changes required for fusion with host membranes.

    • Michael B Battles
    • Johannes P Langedijk
    • Jason S McLellan
    Article
  • Synthetic biology has expanded the availability of engineered bacterial systems for diverse applications and is now developing safeguards for their effective and secure use. The report of two synthetic gene circuit ‘kill switches’ provides new biocontainment mechanisms for engineered Escherichia coli.

    • Clement T Y Chan
    • Jeong Wook Lee
    • James J Collins
    Article
  • [NiFe] hydrogenases contain a conserved arginine (R509) that is suspended over the Ni and Fe atoms. Biochemical, crystallographic and electrochemical analysis of an R509K mutant reveal >100-fold lower oxidation activity despite the maintenance of structural integrity.

    • Rhiannon M Evans
    • Emily J Brooke
    • Fraser A Armstrong
    Article
  • The biosynthesis of iridoids, a class of bicyclic monoterpenes, features an atypical cyclization reaction catalyzed by iridoid synthase (ISY). Crystallographic and biochemical characterization of ISY from Catharanthus roseus provides insights into the ISY enzymatic mechanism and highlights similarities with the homologous progesterone 5β-reductase.

    • Hajo Kries
    • Lorenzo Caputi
    • Sarah E O'Connor
    Brief Communication
  • Characterization of the first class D β-lactamases in Gram-positive bacteria, including the Bacillaceae family, shows that one, BPU-1, is capable of hydrolyzing a wide variety of β-lactam antibiotics and has a unique substrate-binding mode.

    • Marta Toth
    • Nuno Tiago Antunes
    • Sergei B Vakulenko
    Article
  • Structure and functional characterization of BpHep, a heparanase from the invasive pathogenic bacterium Burkholderia pseudomallei, defines its glycosaminoglycan recognition mechanism and its catalytic mechanism as an endo-acting glycoside hydrolase.

    • Lisa Bohlmann
    • Gregory D Tredwell
    • Mark von Itzstein
    Brief Communication
  • Chemoproteomic studies have revealed that a Wnt-pathway inhibitor, CCT251545, is a potent and selective small-molecule chemical probe that inhibits the Mediator complex–associated protein kinases CDK8 and CDK19 through a type 1 binding mode and modulates the growth of Wnt-dependent tumors.

    • Trevor Dale
    • Paul A Clarke
    • Julian Blagg
    Article